Minerva Neurosciences
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NERV and other ETFs, options, and stocks.About NERV
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease.
NERV Key Statistics
Stock Snapshot
As of today, Minerva Neurosciences(NERV) shares are valued at $5.10. The company's market cap stands at 238.3M, with a P/E ratio of -0.17.
On 2026-07-05, Minerva Neurosciences(NERV) stock moved within a range of $4.73 to $5.36. With shares now at $5.10, the stock is trading +7.8% above its intraday low and -4.9% below the session's peak.
Trading activity shows a volume of 284.73K, compared to an average daily volume of 608.89K.
The stock's 52-week range extends from a low of $1.59 to a high of $12.46.
The stock's 52-week range extends from a low of $1.59 to a high of $12.46.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.